The repurposing of PTH anti-psychotics for cancer therapy has been proposed (Lee et al., 2016), even though their cellular targets have not been identified, as they were generally assumed to work largely through inhibition of dopamine receptors (Yin et al., 2015). Here, PTH is linked to cancer.